Search / 4 results found


LOS ANGELES — In the latest twist to the bizarre situation surrounding the California Horse Racing Board's equine medical director, Dr. Jeff Blea has been placed on administrative leave by UC Davis pending further review of his veterinary license. Blea has not been performing the functions of EMD since Thursday after state attorneys indicated he needed a veterinary license. The board was ...

  • Updated

ABBOTT PARK, Ill., Jan. 4, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim™ XR Spinal Cord Stimulation (SCS) System with Octrode™ leads. The new labeling lifts MRI restrictions for lead tip location and the amount of radiofrequency power that can be used as part of the normal operating mode of an MRI scan. The expanded labeling covers the majority of Proclaim XR patients, providing additional benefits to those patients and their health care providers.